Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc > EBIT

Aquestive Therapeutics Inc EBIT Chart (AQST)

Aquestive Therapeutics Inc annual/quarterly EBIT from 2006 to 2018. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Aquestive Therapeutics Inc EBIT for the quarter ending December 12, 2018 was $-12m a 142.96% decrease of -18m year over year
  • Aquestive Therapeutics Inc EBIT for the last 12 months ending December 12, 2018 was $-24m a 118.25% decrease of -29m year over year
  • Aquestive Therapeutics Inc Annual EBIT for 2018 was $-24m a 99.53% decrease of -24m from 2017
  • Aquestive Therapeutics Inc Annual EBIT for 2017 was $0m a -649.56% increase of 1m from 2016
  • Aquestive Therapeutics Inc Annual EBIT for 2016 was $-1m a -1,340.02% increase of 11m from 2015
Other Income Statement Metrics:
  • Aquestive Therapeutics Inc EBITDA for the quarter ending December 12, 2018 was $-12m a 154.38% decrease of -18m year over year
  • Aquestive Therapeutics Inc Net Income for the quarter ending December 12, 2018 was $-14m a 129.40% decrease of -18m year over year
  • Aquestive Therapeutics Inc Total Revenue for the quarter ending December 12, 2018 was $17m a -39.15% decrease of -7m year over year
View Chart On Koyfin

Quarterly AQST EBIT Data

12/2018$-12m
09/2018$-9m
06/2018$-33m
03/2018$5m
12/2017$-7m
09/2017$10m
06/2017$-4m
03/2017$1m
06/2007$-4m
03/2007$-4m

Annual AQST EBIT Data

2018$-24m
2017$0m
2016$-1m
2006$-12m
2005$-8m
2004$-4m